Your browser is no longer supported. Please, upgrade your browser.
PRGO Perrigo Company plc daily Stock Chart
Perrigo Company plc
IndexS&P 500 P/E- EPS (ttm)-0.95 Insider Own0.10% Shs Outstand145.79M Perf Week4.54%
Market Cap13.17B Forward P/E11.72 EPS next Y7.71 Insider Trans-7.71% Shs Float137.14M Perf Month-7.01%
Income-134.70M PEG- EPS next Q1.59 Inst Own75.20% Short Float4.96% Perf Quarter-2.23%
Sales5.63B P/S2.34 EPS this Y-95.80% Inst Trans0.09% Short Ratio3.28 Perf Half Y-8.86%
Book/sh69.14 P/B1.31 EPS next Y10.12% ROA-0.70% Target Price102.47 Perf Year-38.53%
Cash/sh- P/C- EPS next 5Y7.98% ROE-1.30% 52W Range82.37 - 167.07 Perf YTD-37.32%
Dividend0.58 P/FCF25.82 EPS past 5Y-59.80% ROI0.60% 52W High-45.94% Beta0.66
Dividend %0.64% Quick Ratio1.00 Sales past 5Y0.10% Gross Margin39.00% 52W Low9.64% ATR2.44
Employees13242 Current Ratio1.40 Sales Q/Q-3.30% Oper. Margin0.50% RSI (14)49.39 Volatility2.22% 2.69%
OptionableYes Debt/Eq0.65 EPS Q/Q251.30% Profit Margin-2.40% Rel Volume1.15 Prev Close88.51
ShortableYes LT Debt/Eq0.57 EarningsOct 27 BMO Payout- Avg Volume2.08M Price90.31
Recom2.90 SMA20-1.77% SMA50-1.19% SMA200-16.59% Volume2,382,669 Change2.03%
Aug-11-16Reiterated Barclays Overweight $120 → $110
Jul-22-16Upgrade Deutsche Bank Hold → Buy $115
Jun-20-16Downgrade Argus Buy → Hold
Apr-26-16Reiterated RBC Capital Mkts Sector Perform $140 → $109
Apr-26-16Reiterated Barclays Overweight $180 → $120
Apr-25-16Downgrade Wells Fargo Outperform → Market Perform
Apr-25-16Downgrade BofA/Merrill Buy → Underperform
Feb-22-16Downgrade Goldman Neutral → Sell
Feb-19-16Initiated Wells Fargo Outperform
Feb-19-16Downgrade B. Riley & Co. Buy → Neutral $239 → $146
Jan-21-16Initiated Barclays Overweight $180
Dec-10-15Upgrade Argus Hold → Buy $170
Dec-03-15Initiated Morgan Stanley Equal-Weight
Nov-24-15Reiterated B. Riley & Co. Buy $229 → $237
Nov-18-15Resumed JP Morgan Neutral
Nov-16-15Upgrade UBS Neutral → Buy $200
Oct-23-15Reiterated B. Riley & Co. Neutral $218 → $229
Jun-03-15Reiterated B. Riley & Co. Neutral $195 → $216
Apr-27-15Downgrade B. Riley & Co. Buy → Neutral
Apr-22-15Reiterated B. Riley & Co. Buy $189 → $195
Oct-21-16 11:20AM  7 Blue-Chip Stocks That Are Due for a Turnaround at Kiplinger
Oct-19-16 01:32PM  ETFs with exposure to Perrigo Co. Plc : October 19, 2016
Oct-17-16 01:36PM  Jerome Dodson Goes 2 for 2 in 3rd Quarter
Oct-14-16 02:15PM  Stressed Out: Free Cash Flow Is All That Counts Now for Valeant
Oct-10-16 08:39AM  Perrigo Co. Plc breached its 50 day moving average in a Bearish Manner : PRGO-US : October 10, 2016
Sep-27-16 06:10PM  Teva Is Well Positioned for New Trends in the US Generic Market
11:04AM  Tevas OTC Business Is Playing out to Be a Key Growth Driver
08:15AM  Perrigo Invests In Tarex® Patented Technology, As A Key Investment In The Fight Against Methamphetamine Drug Abuse PR Newswire
Sep-21-16 08:04AM  What Is the Upside Potential for Valeant?
Sep-20-16 11:04AM  How Will Valeants Profitability Pan Out over the Long Term?
10:20AM  Perrigo Could Rake In $2.8 Billion in Tysabri Divestitures, Analysts Say
10:04AM  Why Valeant Offers Volume-Based Discounts for These Drugs
Sep-19-16 02:03PM  Barclays Sees 44-48% Upside In Perrigo Shares; Co. Remains Vulnerable To Activist Investors
Sep-16-16 05:48PM  Arbor and Purdue Seen as Likely Bidders for DepoMed
04:52PM  Perrigo explores sale of royalties of drug Tysabri: sources
03:39PM  Perrigo explores sale of royalties of drug Tysabri -sources
Sep-14-16 07:50PM  [$$] Governance Change Needed at Mylan at The Wall Street Journal
01:19PM  Is Starboard Butting in at Perrigo? at Investopedia
Sep-13-16 04:30PM  Perrigo Up as Starboard Reveals Stake, Changes Proposed
02:16PM  Making a Loss Look Like a Profit: Where Perrigo Led the S&P 500
12:58PM  Perrigo Activist Campaign Was Inevitable, Says Expert at The Wall Street Journal
10:14AM  Deutsche Bank Echoes Starboard's Sentiment: Perrigo Is Undervalued
10:10AM  Company News for September 13, 2016
09:55AM  Hedge Funds Issue Open Letters
12:41AM  Asian stocks advance after worries over Fed rate hike ease AP
12:28AM  PRESS DIGEST- New York Times business news - Sept 13 Reuters
12:10AM  [$$] A Fitter Perrigo Is in Activists Interest at The Wall Street Journal
Sep-12-16 06:37PM  [$$] Perrigo shares jump as activist Starboard's stake revealed at Financial Times +7.35%
05:40PM  Business Highlights AP
04:25PM  Perrigo Jumps As Starboard Reveals Big Stake, Demands Changes
04:05PM  Promises, Promises: Perrigo Is Latest Company Haunted by Predictions at The Wall Street Journal
03:55PM  Activist Starboard demands rapid changes at Perrigo
03:16PM  7 Stocks Trading on Big Volume -- and What to Do With Them Now
02:39PM  Starboard buys stake in drugmaker Perrigo, wants shakeup
02:26PM  [$$] A Fitter Perrigo Is in Activists' Interest at The Wall Street Journal
01:16PM  Perrigo CEO Says Review Ongoing, Activist Starboard Takes Stake
12:58PM  Starboard Gives Perrigo Needed Urgency at Bloomberg
10:55AM  US STOCKS-Tech boost helps Wall St reverse course to trade higher
10:27AM  A.M. Funds Roundup: Calm Doesn't Always End in a Storm; What's In Your Growth and Value Index Funds? at
10:02AM  US STOCKS-Wall St opens lower as investors fret over Sept rate hike
09:54AM  The advances in fight against Zika
09:44AM  Perrigo Shares Spike After Starboard's Smith Urges Asset Sales
08:50AM  Morning Movers: PRGO, MYL, HPQ, MRO, RIG
08:10AM  Perrigo Acknowledges Receipt Of Letter From Starboard Value LP PR Newswire
08:04AM  Price Erosion Could Impact Perrigos Prescription Drug Business
08:04AM  Perrigo (PRGO) Stock Advances, Starboard Discloses 4.6% Stake
07:16AM  Starboard discloses 4.6 percent stake in Perrigo, seeks changes
07:02AM  Perrigo's stock surges after Starboard discloses stake at MarketWatch
06:49AM  Starboard Discloses 4.6% Ownership in Perrigo and Delivers Letter to the CEO and Board of Directors PR Newswire
12:31AM  [$$] Starboard Value Takes 4.6% Stake in Perrigo, Worth Nearly $600 Million at The Wall Street Journal
Sep-11-16 11:17PM  Perrigo Targeted by Activist Starboard With New 4.6% Stake at Bloomberg
11:17PM  Perrigo Targeted by Activist Investor Starboard With 4.6% Stake
11:00PM  [$$] Starboard Value Takes 4.6% Stake in Perrigo at The Wall Street Journal
Sep-09-16 04:04PM  PERRIGO CO PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:04PM  Whats Expected from the Branded Consumer Healthcare Segment?
03:04PM  Consumer Healthcare Segment Expects Revenue of $2.6 Billion in 2016
12:37PM  What Are Analysts Recommendations for Perrigo in 2016?
Sep-08-16 11:06AM  Perrigo Co. Plc Value Analysis (NYSE:PRGO) : September 8, 2016
Sep-07-16 10:06AM  Perrigo Company to Present at Upcoming Investor Conferences PR Newswire
08:26AM  Perrigo Co. Plc breached its 50 day moving average in a Bullish Manner : PRGO-US : September 7, 2016
Sep-02-16 12:43PM  Perrigo Co. Plc : PRGO-US: Dividend Analysis : August 26th, 2016 (record date) : By the numbers : September 2, 2016
Sep-01-16 09:01AM  Perrigo Announces Tentative FDA Approval For Generic Version Of Epiduo® Gel PR Newswire
Aug-30-16 09:43AM  Einhorn Loves These 5 Stocks -- but What Do the Charts Say?
08:04AM  Akorn Expected to Report Strong Revenue Growth in 2016
Aug-25-16 01:29PM  [$$] Mylan: pen is not mightier at Financial Times
11:22AM  How Mylan's EpiPen Fight Could Sting Investors at The Wall Street Journal
Aug-24-16 07:50AM  10 Stocks Billionaire David Einhorn Loves in 2016
Aug-23-16 11:04AM  Will Anda Acquisition Improve Access to Tevas Generic Drugs?
09:10AM  Perrigo Announces Tentative FDA Approval For Generic Version Of Suprep® Oral Solution And Confirms Patent Challenge For Generic Version Of Mirvaso® Gel PR Newswire
Aug-19-16 11:25AM  What Are Analysts Recommending for Teva Pharmaceutical in 2016?
Aug-17-16 11:04AM  How Did Valeant Manage Its Operating Expenses in 2Q16?
07:46AM  Perrigo to Acquire U.S. Distributor of Healthcare & Consumer Goods Products, Geiss, Destin & Dunn PR Newswire
Aug-16-16 07:00AM  Our Ultimate Stock-Pickers Top 10 New-Money Purchases at Morningstar
Aug-15-16 09:15AM  Post Earnings Coverage as Perrigo Doubles Profit
Aug-14-16 07:18AM  3 Beaten-Up Big Pharma Stocks: Are They Bargains? at Motley Fool
Aug-12-16 11:05AM  What Are Valeants New Segments?
Aug-11-16 02:12PM  Deutsche Thinks Perrigo's Lowered Expectations Are Beatable
01:04PM  ETFs with exposure to Perrigo Co. Plc : August 11, 2016
10:44AM  Perrigo: A High Price to Pay for Uncertainty at
10:10AM  Stock Market News for August 11, 2016
09:56AM  Perrigo (PRGO) Stock Slumps, Price Target Cut at Deutsche Bank
Aug-10-16 11:16PM  [$$] Business Watch at The Wall Street Journal -9.56%
04:39PM  Edited Transcript of PRGO earnings conference call or presentation 10-Aug-16 12:30pm GMT
04:16PM  Perrigo Company plc -- Moody's affirms Perrigo's Baa3 rating; changes outlook to negative at Moody's
01:28PM  Cant stomach volatile Valeant shares? Analysts like its bonds better at MarketWatch
01:26PM  Good, bad, & ugly: HBI, airlines & PRGO
01:01PM  More Squawk from Jim Cramer: Perrigo (PRGO) Quarter Was 'Problematic'
12:58PM  Perrigo Has a Warning for Valeant at Bloomberg
12:50PM  Many 52-Week Lows, Even as Stock Market at All-Time Highs: SunPower, Myriad, Perrigo, Tidewater and More at 24/7 Wall St.
12:48PM  Why Hendrickson-Led Perrigo Is A Good Bet For Long Term Investors
12:48PM  Jim Cramer: Perrigo is Problematic at TheStreet
10:49AM  Perrigo (PRGO) Misses Q2 Earnings Estimates, Cuts '16 View
10:36AM  Why I Feel Bearish About the Market
10:33AM  Don't 'Catch a Falling Knife' with Perrigo
09:53AM  US STOCKS-Wall St flat as investors pause after record-setting day
09:13AM  The Market In 5 Minutes: Stocks Still In Tight Range, Disney And Michael Kors Fall On Earnings
08:41AM  Perrigo (PRGO) Stock Slumps on Q2 Earnings Miss, Downbeat Guidance
08:33AM  Morning Movers: Myriad Genetics Craters on Guidance; Disney Drops at
08:08AM  [$$] Perrigo Misses Expectations and Cuts Guidance at The Wall Street Journal
08:07AM  Perrigo Co. Plc breached its 50 day moving average in a Bullish Manner : PRGO-US : August 10, 2016
Perrigo Company plc, together with its subsidiaries, develops, manufactures, markets, and distributes over-the-counter (OTC) consumer goods and pharmaceutical products worldwide. The company operates through Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx), Specialty Sciences, and Other segments. The CHC segment offers OTC products in various categories, including analgesics, cough/cold/allergy/sinus, gastrointestinal, infant nutritional, smoking cessation, animal health, feminine hygiene, diabetes and dermatological care, diagnostic, scar management, and other healthcare products, as well as vitamins, minerals, and dietary supplements (VMS); and contract manufacturing services. It serves retail drug, supermarket, mass merchandise chains, and wholesalers through sales force and industry brokers. The BCH segment provides branded OTC products in the natural health and VMS; cough, cold, flu, and allergy; personal care and derma-therapeutics; lifestyle; pain relief, nasal decongestants, and cold sore management; and anti-parasite areas, as well as offers generic pharmaceutical products. It serves pharmacies, drug, and grocery stores through pharmacy sales force, as well as a network of pharmacists. The Rx segment offers generic and specialty pharmaceutical prescription drugs in various dosage forms, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, women's health products, oral solid dosage forms, and oral liquid formulations; and ORx products. It serves wholesalers; retail drug, supermarket, and mass merchandise chains; hospitals; and pharmacies. The Specialty Sciences segment offers Tysabri to treat multiple sclerosis. The Other segment offers active pharmaceutical ingredients used by generic and branded pharmaceutical companies. The company was founded in 1887 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Farrington ThomasEVP and CIOSep 26Sale96.761,110107,4042,970Sep 28 01:47 PM
Brown Judy LEVP, Business Ops & CFOSep 26Sale96.762,096202,80914,196Sep 28 01:47 PM
KUNKLE GARY K JRDirectorSep 09Option Exercise16.775,81497,50131,501Sep 13 03:01 PM
KUNKLE GARY K JRDirectorSep 09Sale89.955,814522,97425,687Sep 13 03:01 PM
MORRIS HERMAN JRDirectorSep 08Option Exercise16.775,81497,50110,425Sep 09 04:33 PM
MORRIS HERMAN JRDirectorSep 08Sale90.961,07397,5959,352Sep 09 04:33 PM
Brown Judy LEVP, Business Ops & CFOAug 26Sale88.282,095184,94716,292Aug 30 04:38 PM
Weninger PaulEVP, Quality OperationsAug 22Option Exercise91.5218817,2062,296Aug 24 03:54 PM
Brown Judy LEVP, Business Ops & CFOAug 22Option Exercise91.522,877263,30319,717Aug 24 03:53 PM
Farrington ThomasEVP and CIOAug 22Option Exercise91.5269363,4234,299Aug 24 03:53 PM
Quinn GrainneEVP, Chief Medical OfficerAug 22Option Exercise91.522,168198,4153,208Aug 24 03:53 PM
Needham JeffreyEVP, GM Consumer HealthcareAug 22Option Exercise91.521,336122,27111,327Aug 24 03:52 PM
Janish Ronald CraigEVP, Global Op. & Supply ChainAug 22Option Exercise91.5230127,5481,586Aug 24 03:52 PM
HENDRICKSON JOHN TCEOAug 22Option Exercise91.521,536140,5755,401Aug 24 03:52 PM
Kochan SharonEVP, GM InternationalAug 22Option Exercise91.521,336122,27110,088Aug 24 03:51 PM
KINGMA TODD WExecutive VP, General CounselAug 22Option Exercise91.521,536140,57515,796Aug 23 04:58 PM
KINGMA TODD WExecutive VP, General CounselAug 19Option Exercise91.831,692155,37612,012Aug 23 04:58 PM
Kochan SharonEVP, GM InternationalAug 19Option Exercise91.831,01593,2076,898Aug 23 04:57 PM
Needham JeffreyEVP, GM Consumer HealthcareAug 19Option Exercise91.8333831,0397,678Aug 23 04:57 PM
Farrington ThomasEVP and CIOAug 19Option Exercise91.831,692155,3762,886Aug 23 04:57 PM
HENDRICKSON JOHN TCEOAug 19Option Exercise91.831,692155,3761,692Aug 23 04:56 PM
Brown Judy LEVP, Business Ops & CFOAug 19Option Exercise91.831,692155,37614,121Aug 23 04:58 PM
JANDERNOA MICHAEL JDirectorMay 04Option Exercise95.7092488,4278,774May 06 04:23 PM
MORRIS HERMAN JRDirectorMay 04Option Exercise95.7092488,4275,055May 06 04:23 PM
FOUSE JACQUALYN ADirectorMay 04Option Exercise95.7092488,4274,360May 06 04:24 PM
COHEN GARY MDirectorMay 04Option Exercise95.7092488,42713,795May 06 04:24 PM
Yanai ShlomoDirectorMay 04Option Exercise95.7092488,427924May 06 04:22 PM
BRLAS LAURIEDirectorMay 04Option Exercise95.7092488,42710,901May 06 04:22 PM
KUNKLE GARY K JRDirectorMay 04Option Exercise95.7092488,42726,131May 06 04:23 PM
Hoffing Ellen RandiDirectorMay 04Option Exercise95.7092488,4279,528May 06 04:24 PM
Brown Judy LExecutive VP & CFOApr 13Option Exercise113.772,776315,82513,924Apr 14 03:38 PM
Brown Judy LExecutive VP & CFOApr 13Sale126.222,776350,38712,429Apr 14 03:38 PM
JANDERNOA MICHAEL JDirectorMar 18Option Exercise16.775,81497,5018,611Mar 22 04:31 PM
JANDERNOA MICHAEL JDirectorMar 18Sale128.2976197,6297,850Mar 22 04:31 PM
Kochan SharonEVP, GM InternationalMar 02Sale125.281,490186,6675,883Mar 04 02:43 PM
Brown Judy LExecutive VP & CFOFeb 24Option Exercise113.772,776315,82513,924Feb 26 03:07 PM
Brown Judy LExecutive VP & CFOFeb 24Sale123.732,776343,47412,429Feb 26 03:07 PM
PERRIGO Co plc10% OwnerFeb 17Buy8.00125,0001,000,0002,908,067Feb 18 05:50 PM
Brown Judy LExecutive VP & CFOJan 06Option Exercise83.1227,7372,305,62426,518Jan 08 03:27 PM
Brown Judy LExecutive VP & CFOJan 06Sale142.4127,7373,950,07512,429Jan 08 03:27 PM
PAPA JOSEPH CCEODec 28Option Exercise58.8210,183598,964129,598Dec 30 03:18 PM
PAPA JOSEPH CCEODec 28Sale147.0710,1831,497,579119,415Dec 30 03:18 PM
Farrington ThomasEVP and CIONov 30Sale151.0335052,8611,194Dec 02 09:29 AM
Gottfried RanDirectorNov 19Option Exercise100.842,726274,89015,454Nov 23 04:17 PM
Gottfried RanDirectorNov 19Sale154.342,726420,72212,728Nov 23 04:17 PM
MORRIS HERMAN JRDirectorNov 18Sale155.6455085,602850Nov 20 07:35 PM
KUNKLE GARY K JRDirectorNov 13Option Exercise146.901,929283,37026,133Nov 17 04:57 PM
JANDERNOA MICHAEL JDirectorNov 13Option Exercise146.901,929283,3702,797Nov 17 04:57 PM
BRLAS LAURIEDirectorNov 13Option Exercise146.901,929283,37010,903Nov 17 04:58 PM
Hoffing Ellen RandiDirectorNov 13Option Exercise146.901,929283,3709,530Nov 17 04:56 PM
FOUSE JACQUALYN ADirectorNov 13Option Exercise146.901,929283,3704,362Nov 17 04:56 PM
COHEN GARY MDirectorNov 13Option Exercise146.901,929283,37013,797Nov 17 04:56 PM
MORRIS HERMAN JRDirectorNov 13Option Exercise146.901,929283,3705,057Nov 17 04:57 PM
O'Connor DonalDirectorNov 13Option Exercise146.901,929283,3702,173Nov 17 04:57 PM
GIBBONS DAVID TDirectorNov 04Option Exercise162.291,929313,05715,104Nov 05 04:16 PM
Gottfried RanDirectorNov 04Option Exercise162.291,929313,05713,654Nov 06 05:22 PM